Butterfly Network (BFLY) Liabilities and Shareholders Equity (2020 - 2026)
Butterfly Network (BFLY) posted Liabilities and Shareholders Equity of $283.0 million for Q2 2026, down 1.02% sequentially from $285.9 million in Q1 2026, and down 9.67% YoY from $313.3 million in Q2 2025.
Butterfly Network (BFLY) Liabilities and Shareholders Equity (2020 - 2026) Analysis & Trends
Butterfly Network has reported Liabilities and Shareholders Equity for 7 years, with the latest figure at $283.0 million in Q2 2026.
- Quarterly Liabilities and Shareholders Equity fell 9.67% year-over-year to $283.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $1.2 billion (changed 0.21% YoY) and the FY2025 annual result came in at $296.5 million, up 15.8% from the prior year.
- Liabilities and Shareholders Equity declined to $283.0 million in Q2 2026 per BFLY's latest filing, from $285.9 million in the prior quarter.
- Over five years, Liabilities and Shareholders Equity peaked at $535.4 million in Q1 2022 and troughed at $256.1 million in Q4 2024.
- A 5-year average of $341.3 million and a median of $308.8 million in 2023 frame the typical range for Liabilities and Shareholders Equity.
- The sharpest annual moves came in 2023 and 2025: Liabilities and Shareholders Equity fell 28.71% in 2023, then advanced 15.8% in 2025.
- Over 5 years, Liabilities and Shareholders Equity stood at $417.6 million in 2022, then dropped by 27.13% to $304.3 million in 2023, then fell by 15.84% to $256.1 million in 2024, then grew by 15.8% to $296.5 million in 2025, then dropped by 4.57% to $283.0 million in 2026.
- According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $283.0 million, $285.9 million, and $296.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 109.22 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 47.93 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 93.03 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 45.22 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 13.87 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 6.46 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 37.25 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 31.04 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 10.74 Bn |
| 10 | Butterfly Network | 2.41 Bn | 2.28 Bn | 23.29 Mn | 283.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 283.00 Mn |
| Mar 31, 2026 | 285.92 Mn |
| Dec 31, 2025 | 296.53 Mn |
| Sep 30, 2025 | 290.00 Mn |
| Jun 30, 2025 | 313.28 Mn |
| Mar 31, 2025 | 318.41 Mn |
| Dec 31, 2024 | 256.08 Mn |
| Sep 30, 2024 | 265.27 Mn |
| Jun 30, 2024 | 273.07 Mn |
| Mar 31, 2024 | 284.29 Mn |
| Dec 31, 2023 | 304.27 Mn |
| Sep 30, 2023 | 334.22 Mn |
| Jun 30, 2023 | 364.59 Mn |
| Mar 31, 2023 | 381.68 Mn |
| Dec 31, 2022 | 417.57 Mn |
| Sep 30, 2022 | 443.26 Mn |
| Jun 30, 2022 | 496.64 Mn |
| Mar 31, 2022 | 535.42 Mn |
| Dec 31, 2021 | 571.97 Mn |
| Sep 30, 2021 | 580.32 Mn |